X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2459) 2459
Book Review (362) 362
Publication (218) 218
Conference Proceeding (8) 8
Book Chapter (6) 6
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2156) 2156
index medicus (2151) 2151
male (1207) 1207
female (1205) 1205
beta-thalassemia (915) 915
adult (904) 904
hematology (855) 855
thalassemia (632) 632
adolescent (615) 615
beta-thalassemia - pathology (566) 566
child (562) 562
beta-thalassemia - complications (529) 529
beta-thalassemia - genetics (469) 469
beta-thalassemia - blood (349) 349
middle aged (347) 347
beta-thalassemia - therapy (335) 335
anemia (322) 322
child, preschool (299) 299
animals (295) 295
iron overload (285) 285
beta-thalassemia - diagnosis (268) 268
young adult (261) 261
abridged index medicus (251) 251
mutation (246) 246
disease (237) 237
magnetic resonance imaging (228) 228
iron - metabolism (224) 224
iron (219) 219
hemoglobin (205) 205
liver - pathology (198) 198
beta-thalassemia - metabolism (195) 195
ferritins - blood (189) 189
blood transfusion (188) 188
mice (187) 187
diagnosis (183) 183
oncology (183) 183
pathology (183) 183
beta-thalassemia major (160) 160
iron chelating agents - therapeutic use (157) 157
biochemistry & molecular biology (156) 156
iron overload - etiology (156) 156
medicine & public health (153) 153
pediatrics (153) 153
β-thalassemia (150) 150
infant (149) 149
medicine, research & experimental (149) 149
overload (148) 148
children (144) 144
beta-thalassemia - drug therapy (143) 143
phenotype (143) 143
case-control studies (141) 141
liver - metabolism (141) 141
transfusion reaction (141) 141
thalassemia major (139) 139
liver (134) 134
genotype (132) 132
oxidative stress (132) 132
beta-globins - genetics (131) 131
heterozygote (130) 130
iron overload - pathology (128) 128
sickle-cell-disease (128) 128
beta-thalassemia - physiopathology (127) 127
hemic and lymphatic diseases (125) 125
globins - genetics (122) 122
pregnancy (121) 121
prevalence (118) 118
beta-thalassemia - epidemiology (117) 117
deferoxamine (116) 116
analysis (114) 114
sickle cell disease (113) 113
research (111) 111
risk factors (111) 111
aged (110) 110
therapy (110) 110
erythropoiesis (109) 109
expression (109) 109
treatment outcome (108) 108
genetics & heredity (107) 107
iron overload - drug therapy (107) 107
myocardium - pathology (106) 106
alpha-thalassemia (104) 104
magnetic resonance imaging - methods (104) 104
ferritin (103) 103
radiology, nuclear medicine & medical imaging (102) 102
chelation therapy (101) 101
medicine, general & internal (100) 100
retrospective studies (99) 99
transfusion (98) 98
sickle cell anemia (97) 97
biopsy (96) 96
magnetic-resonance (96) 96
medicine (96) 96
care and treatment (95) 95
deferiprone (95) 95
diagnosis, differential (95) 95
intermedia (95) 95
article (94) 94
blood (94) 94
health aspects (94) 94
thalassaemia (93) 93
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2386) 2386
Italian (23) 23
French (20) 20
Japanese (9) 9
Chinese (8) 8
Russian (7) 7
Dutch (2) 2
German (2) 2
Polish (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2011, Volume 141, Issue 4, pp. 1202 - 1211.e3
Background & Aims Most data on the effects of iron chelation therapy for patients with liver fibrosis come from small studies. We studied the effects of the... 
Gastroenterology and Hepatology | Cirrhosis | Therapy | Clinical Trial | Liver Disease | FIBROSIS | TRANSFUSION-DEPENDENT ANEMIAS | CHRONIC HEPATITIS-C | KAPPA-B | DESFERRIOXAMINE | GENETIC HEMOCHROMATOSIS | BONE-MARROW TRANSPLANTATION | CHELATION-THERAPY | IRON-OVERLOADED PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | MYELODYSPLASTIC SYNDROMES | beta-Thalassemia - pathology | Liver - pathology | Benzoates - therapeutic use | Humans | Middle Aged | Child, Preschool | Male | Alanine Transaminase - blood | beta-Thalassemia - complications | Young Adult | Ferritins - blood | Liver - drug effects | Time Factors | Adult | Female | Child | beta-Thalassemia - blood | Triazoles - therapeutic use | Severity of Illness Index | Liver Cirrhosis - drug therapy | Liver Cirrhosis - etiology | Iron Chelating Agents - therapeutic use | Liver - metabolism | Treatment Outcome | Liver Cirrhosis - blood | Biomarkers - blood | Iron - metabolism | Cross-Over Studies | beta-Thalassemia - drug therapy | Biopsy | Adolescent | Liver Cirrhosis - pathology | Hepatitis C - pathology | Index Medicus | Abridged Index Medicus | Benzoic Acids | Alanine Transaminase | Biological Markers | Liver | Iron | Life Sciences | Triazoles | beta-Thalassemia | Hépatology and Gastroenterology | Liver Cirrhosis | Human health and pathology | Iron Chelating Agents | Hepatitis C | Ferritins
Journal Article
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 12/2014, Volume 89, Issue 12, pp. 1102 - 1106
Iron overload in β‐thalassemia major (TM) typically results in iron‐induced cardiomyopathy, liver disease, and endocrine complications. We examined the... 
IMPACT | TRANSFUSIONAL IRON OVERLOAD | MRI | MASS | REPLACEMENT THERAPY | IMPROVEMENT | COMPLICATIONS | PREVALENCE | HEMATOLOGY | HYPOGONADISM | NORTH-AMERICA | Diabetes Mellitus - pathology | Hypothyroidism - pathology | Hypothyroidism - metabolism | Benzoates - therapeutic use | Humans | Middle Aged | Child, Preschool | Male | Puberty, Delayed - metabolism | Iron Overload - etiology | Osteoporosis - metabolism | Hypogonadism - metabolism | Bone and Bones - metabolism | Diphosphonates - therapeutic use | Child | Triazoles - therapeutic use | Iron Chelating Agents - therapeutic use | Hypoparathyroidism - metabolism | beta-Thalassemia - drug therapy | Puberty, Delayed - pathology | Diabetes Mellitus - prevention & control | Osteoporosis - pathology | Adolescent | beta-Thalassemia - metabolism | Hypogonadism - etiology | beta-Thalassemia - pathology | Bone and Bones - pathology | Iron Overload - drug therapy | Calcium - administration & dosage | Chelation Therapy | beta-Thalassemia - complications | Hypoparathyroidism - pathology | Hypoparathyroidism - prevention & control | Iron Overload - pathology | Osteoporosis - etiology | Bone and Bones - drug effects | Hypogonadism - prevention & control | Iron Overload - metabolism | Puberty, Delayed - etiology | Adult | Diabetes Mellitus - etiology | Female | Vitamin D - administration & dosage | Retrospective Studies | Hypothyroidism - prevention & control | Hypogonadism - pathology | Bone Density | Osteoporosis - prevention & control | Diabetes Mellitus - metabolism | Hypothyroidism - etiology | Puberty, Delayed - prevention & control | Hypoparathyroidism - etiology | Index Medicus
Journal Article
American Journal of Hematology, ISSN 0361-8609, 02/2012, Volume 87, Issue 2, pp. 155 - 160
Journal Article
Clinical Chemistry, ISSN 0009-9147, 10/2017, Volume 63, Issue 10, pp. 1614 - 1623
BACKGROUND: There is much interest in the tissue of origin of circulating DNA in plasma. Data generated using DNA methylation markers have suggested that... 
ANEUPLOIDY | NONINVASIVE PRENATAL-DIAGNOSIS | BARR-VIRUS DNA | RAPID CLEARANCE | BLUEPRINT | EPIGENETIC SIGNATURE | CLASSIFICATION | FETAL DNA | MEDICAL LABORATORY TECHNOLOGY | CANCER | BLOOD | Erythropoiesis | beta-Thalassemia - pathology | Anemia - blood | Humans | Erythroblasts - metabolism | beta-Thalassemia - genetics | Anemia - pathology | Myelodysplastic Syndromes - blood | Anemia, Aplastic - blood | Anemia, Iron-Deficiency - blood | DNA - blood | Anemia, Aplastic - diagnosis | Anemia - genetics | DNA Methylation | Anemia, Aplastic - genetics | beta-Thalassemia - blood | Anemia, Aplastic - pathology | Diagnosis, Differential | Anemia - diagnosis | beta-Thalassemia - diagnosis | DNA - genetics | Myelodysplastic Syndromes - diagnosis | Anemia, Iron-Deficiency - diagnosis | Anemia, Iron-Deficiency - genetics | Anemia, Iron-Deficiency - pathology | Ferrochelatase - genetics | Myelodysplastic Syndromes - genetics | Myelodysplastic Syndromes - pathology | Erythroblasts - pathology | Genetic research | Methylation | Analysis | Genes | DNA | Aplastic anemia | Iron | Blood | Blood plasma | Etiology | Lymphocytes | DNA methylation | Bone marrow | Bioindicators | Differential diagnosis | Signatures | Deoxyribonucleic acid--DNA | Quantitative analysis | Nutrient deficiency | Anemia | Ferrochelatase | Neutrophils | Thalassemia | Patients | Loci | Hemopoiesis | Polymerase chain reaction | Erythroblasts | Epigenetics | Biomarkers | Plasmas (physics) | Index Medicus
Journal Article
Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 7, pp. 678 - 684
Recovery from blood loss requires a greatly enhanced supply of iron to support expanded erythropoiesis. After hemorrhage, suppression of the iron-regulatory... 
OVERLOAD | HOMEOSTASIS | DIFFERENTIATION FACTOR 15 | BETA-THALASSEMIA-INTERMEDIA | ERYTHROPOIESIS | GENETICS & HEREDITY | MOUSE-LIVER | MICE | HEPCIDIN EXPRESSION | ANEMIA | HYPOXIA | Hepcidins - metabolism | beta-Thalassemia - pathology | Liver - pathology | Iron Overload - drug therapy | Molecular Sequence Data | Erythropoiesis - drug effects | Male | Gene Expression Profiling | Iron Overload - pathology | Iron Overload - metabolism | Epoetin Alfa | Erythropoietin - metabolism | Real-Time Polymerase Chain Reaction | Anemia - etiology | Disease Models, Animal | Recombinant Proteins - metabolism | Hormones - pharmacology | Enzyme-Linked Immunosorbent Assay | Liver - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Hemorrhage - complications | Hemoglobins - metabolism | Hemorrhage - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Iron - metabolism | Blotting, Western | Erythropoiesis - physiology | Mice, Knockout | Anemia - metabolism | Animals | Mice | beta-Thalassemia - metabolism | Physiological aspects | Genetic research | Genetic aspects | Iron in the body | Hormones | Research | Genetic regulation | Identification and classification | Flow cytometry | Plasma | Phosphorylation | Bone marrow | Homeostasis | Iron | Grants | Metabolism | Gene expression | Experiments | Hemorrhage | Index Medicus
Journal Article
Journal Article
Hemoglobin, ISSN 0363-0269, 01/2007, Volume 31, Issue 2, pp. 233 - 241
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 06/2015, Volume 55, Issue 1, pp. 82 - 88
The aim of the study was to assess the current state in terms of liver and heart iron overload as well as of liver and heart related morbidity and mortality in... 
Iron overload | Hemangioendothelioma | Thalassemia major | Combination therapy | Iron free foci | FIBROSIS | DESFERRIOXAMINE | FAILURE | TRANSIENT ELASTOGRAPHY | HEPATOCELLULAR-CARCINOMA | DEFEROXAMINE | BETA-THALASSEMIA | HEMATOLOGY | HEPATITIS-C | COMBINED CHELATION-THERAPY | beta-Thalassemia - pathology | Hemosiderosis - etiology | Liver - pathology | Hemangioendothelioma - etiology | Humans | Middle Aged | Liver Cirrhosis - mortality | Child, Preschool | Deferoxamine - therapeutic use | Infant | Male | Liver Neoplasms - mortality | beta-Thalassemia - mortality | Hemosiderosis - pathology | Hemosiderosis - drug therapy | Liver Neoplasms - etiology | Hemangioendothelioma - pathology | Liver - drug effects | Myocardium - metabolism | Adult | Female | Liver Neoplasms - pathology | Drug Therapy, Combination | Child | Severity of Illness Index | Liver Cirrhosis - drug therapy | Liver Cirrhosis - etiology | Iron Chelating Agents - therapeutic use | beta-Thalassemia - therapy | Hemangioendothelioma - mortality | Liver - metabolism | Liver Neoplasms - surgery | Myocardium - pathology | Iron - metabolism | Transfusion Reaction | Hemosiderosis - mortality | Hemangioendothelioma - surgery | Adolescent | Survival Analysis | Liver Cirrhosis - pathology | Pyridones - therapeutic use | beta-Thalassemia - metabolism | Cohort Studies | Thalassemia | Hepatitis C virus | Liver cirrhosis | Mortality | Liver | Cardiac patients | Index Medicus
Journal Article